Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $252.7400 (-0.41%) ($252.7400 - $252.7400) on Fri. Feb. 10, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.28% (three month average) | RSI | 43 | Latest Price | $252.7400(-0.41%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | UTHR declines -1.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) XLV(45%) IBB(43%) SPLV(38%) DIA(35%) VYM(35%) | Factors Impacting UTHR price | UTHR will decline at least -0.64% in a week (0% probabilities). VXX(-21%) VIXM(-13%) UUP(-9%) TBT(-4%) SHY(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.64% (StdDev 1.28%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $258.47 | 5 Day Moving Average | $254.11(-0.54%) | 10 Day Moving Average | $256.07(-1.3%) | 20 Day Moving Average | $258.47(-2.22%) | To recent high | -9.9% | To recent low | 0% | Market Cap | $11.211b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |